Analytical Data
-
Gene name
UBL4A
- Application
-
Alternative Names
DX254E; DXS254E; G6PD; GDX; OTTHUMP00000061462; Ubiquitin like 4; Ubiquitin like 4A; Ubiquitin like Protein 4A; Ubiquitin like Protein GDX; Ubiquitin-like Protein 4A; Ubiquitin-like Protein GDX; UBL 4; UBL 4A; UBL4; Ubl4a; UBL4A_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P11441
-
Expression Region
1-157 aa
-
AA Sequence
MQLTVKALQG RECSLQVPED ELVSTLKQLV SEKLNVPVRQ QRLLFKGKAL ADGKRLSDYS IGPNSKLNLV VKPLEKVLLE EGEAQRLADS PPPQVWQLIS KVLARHFSAA DASRVLEQLQ RDYERSLSRL TLDDIERLAS RFLHPEVTET MEKGFSK
-
Molecular Weight
17.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UBL4A, or Ubiquitin-like protein 4A, is a highly conserved protein that plays a crucial role in various cellular processes, including protein degradation, cell cycle regulation, and stress responses. As a member of the ubiquitin-like protein family, UBL4A is involved in the modification of target proteins, influencing their stability and function. Recent studies have highlighted its involvement in signaling pathways associated with cancer progression and neurodegenerative diseases, underscoring its potential as a therapeutic target. Emerging research aims to elucidate the molecular mechanisms underlying UBL4A interactions and functions, as well as its regulatory roles in cellular homeostasis. Understanding the structure and activity of UBL4A may open avenues for novel drug development strategies, particularly in targeting diseases linked to protein misfolding and degradation. This growing body of research emphasizes the need for recombinant UBL4A protein to study its biochemistry in detail, paving the way for advances in oncology and other biomedical fields.
